RotaShield®
Company
Wyeth Laboratories
Use
Prevention of rotavirus gastroenteritis in infants.
Features
A live oral vaccine, RotaShield® is the first rotavirus vaccine approved for use in humans. It prevents severe acute gastroenteritis caused by rotavirus. FDA approved in 1998.
NIH Contribution
NIH contributed through research in virology and vaccine development.
HHS Institute/Agency
NIAID
Inventor(s)
Wyatt, R. et al.
Year
1998
